292 related articles for article (PubMed ID: 25058862)
1. Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients.
Fillatre P; Decaux O; Jouneau S; Revest M; Gacouin A; Robert-Gangneux F; Fresnel A; Guiguen C; Le Tulzo Y; Jégo P; Tattevin P
Am J Med; 2014 Dec; 127(12):1242.e11-7. PubMed ID: 25058862
[TBL] [Abstract][Full Text] [Related]
2. All patients with leukemia are not equally at risk of contracting Pneumocystis jirovecii pneumonia.
Antoine R; Caroline B; François V;
Am J Med; 2015 Jan; 128(1):e9. PubMed ID: 25553637
[No Abstract] [Full Text] [Related]
3. The reply.
Fillatre P; Revest M; Tattevin P
Am J Med; 2015 Jan; 128(1):e11. PubMed ID: 25553629
[No Abstract] [Full Text] [Related]
4. [Pneumocystosis in non-HIV-infected immunocompromised patients].
Fillâtre P; Revest M; Belaz S; Robert-Gangneux F; Zahar JR; Roblot F; Tattevin P
Rev Med Interne; 2016 May; 37(5):327-36. PubMed ID: 26644039
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment.
Roblot F; Le Moal G; Kauffmann-Lacroix C; Bastides F; Boutoille D; Verdon R; Godet C; Tattevin P;
Scand J Infect Dis; 2014 Mar; 46(3):210-4. PubMed ID: 24450839
[TBL] [Abstract][Full Text] [Related]
7. Fact or fiction: does the non-HIV/AIDS immunosuppressed patient need Pneumocystis jiroveci pneumonia prophylaxis? An updated literature review.
Grewal P; Brassard A
J Cutan Med Surg; 2009; 13(6):308-12. PubMed ID: 19919808
[TBL] [Abstract][Full Text] [Related]
8. Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients.
Ricciardi A; Gentilotti E; Coppola L; Maffongelli G; Cerva C; Malagnino V; Mari A; Di Veroli A; Berrilli F; Apice F; Toschi N; Di Cave D; Parisi SG; Andreoni M; Sarmati L
PLoS One; 2017; 12(5):e0176881. PubMed ID: 28505159
[TBL] [Abstract][Full Text] [Related]
9. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients.
Bollée G; Sarfati C; Thiéry G; Bergeron A; de Miranda S; Menotti J; de Castro N; Tazi A; Schlemmer B; Azoulay E
Chest; 2007 Oct; 132(4):1305-10. PubMed ID: 17934116
[TBL] [Abstract][Full Text] [Related]
10. Aggressive immunosuppressant reduction and long-term rejection risk in renal transplant recipients with Pneumocystis jiroveci pneumonia.
Yang CY; Shih CJ; Yang WC; Lin CC
Exp Clin Transplant; 2012 Aug; 10(4):344-9. PubMed ID: 22765304
[TBL] [Abstract][Full Text] [Related]
11. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients.
Roblot F; Godet C; Le Moal G; Garo B; Faouzi Souala M; Dary M; De Gentile L; Gandji JA; Guimard Y; Lacroix C; Roblot P; Becq-Giraudon B
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):523-31. PubMed ID: 12172743
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases.
Arend SM; Kroon FP; van't Wout JW
Arch Intern Med; 1995 Dec 11-25; 155(22):2436-41. PubMed ID: 7503602
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis.
Gonzalez Santiago TM; Wetter DA; Kalaaji AN; Limper AH; Lehman JS
Int J Dermatol; 2016 Aug; 55(8):823-30. PubMed ID: 27009930
[TBL] [Abstract][Full Text] [Related]
14. Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia.
Agrawal AK; Chang PP; Feusner J
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e1-4. PubMed ID: 21102354
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004.
Overgaard UM; Helweg-Larsen J
Scand J Infect Dis; 2007; 39(6-7):589-95. PubMed ID: 17577823
[TBL] [Abstract][Full Text] [Related]
16. Impact of pneumocystosis on the Spanish health care system, 1997-2020: Profile of HIV and non-HIV immunocompromised patients.
Varas Vicente P; Parra Fariñas R; Alonso-Sardón M; Benéitez Andrés E; Rodriguez Alonso B; Romero-Alegría Á; Almeida H; Muro A; Pardo-Lledias J; Belhassen-García M
J Infect Public Health; 2023 Jun; 16(6):831-840. PubMed ID: 37030036
[TBL] [Abstract][Full Text] [Related]
17. Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.
Caselli D; Petris MG; Rondelli R; Carraro F; Colombini A; Muggeo P; Ziino O; Melchionda F; Russo G; Pierani P; Soncini E; DeSantis R; Zanazzo G; Barone A; Cesaro S; Cellini M; Mura R; Milano GM; Meazza C; Cicalese MP; Tropia S; De Masi S; Castagnola E; Aricò M;
J Pediatr; 2014 Feb; 164(2):389-92.e1. PubMed ID: 24252793
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.
Hardak E; Neuberger A; Yigla M; Berger G; Finkelstein R; Sprecher H; Oren I
Respirology; 2012 May; 17(4):681-6. PubMed ID: 22390188
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis pneumonia.
Gilroy SA; Bennett NJ
Semin Respir Crit Care Med; 2011 Dec; 32(6):775-82. PubMed ID: 22167405
[TBL] [Abstract][Full Text] [Related]
20. A heart transplant recipient lost due to Pneumocystis jiroveci pneumonia under trimethoprim-sulfamethoxazole prophylaxis: case report.
Celik T; Gedik E; Kayabas U; Bayindir Y; Gulbas G; Firat AK; Togal T
Exp Clin Transplant; 2010 Dec; 8(4):325-8. PubMed ID: 21143101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
